Natural course of untreated obstructive sleep apnea in adults with coronary artery disease in the RICCADSA cohort.

Ann Am Thorac SocSep 1, 2026
Clinical ResearchCardiologyPulmonology

Yüksel Peker, Mustafa Saygin, Yeliz Celik et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial examined the natural course of untreated obstructive sleep apnea (OSA) in 119 adults with coronary artery disease (CAD) after revascularization. The study found that 61.3% of patients improved in OSA severity after one year, with a median apnea-hypopnea index (AHI) decreasing from 24.5 to 15.1 events/hour. Patients who improved had a significantly lower risk for major cardiovascular and cerebrovascular events (MACCEs).

Key findings

  • 61.3% of patients improved in OSA severity after one year.
  • Median AHI decreased from 24.5 to 15.1 events/hour.
  • Patients with improved OSA had a lower risk for MACCEs (HR = 0.25).
  • Control group had a median AHI of 4.4 events/hour after one year.

Why it matters

Understanding the trajectory of OSA in CAD patients post-revascularization is crucial for identifying those at risk for adverse cardiovascular events. This knowledge can guide targeted interventions and improve patient outcomes.

Source

Published in Ann Am Thorac Soc. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.